Country: United States
Language: English
Source: NLM (National Library of Medicine)
FLUPHENAZINE HYDROCHLORIDE (UNII: ZOU145W1XL) (FLUPHENAZINE - UNII:S79426A41Z)
NCS HealthCare of KY, Inc dba Vangard Labs
FLUPHENAZINE HYDROCHLORIDE
FLUPHENAZINE HYDROCHLORIDE 5 mg
ORAL
PRESCRIPTION DRUG
Fluphenazine hydrochloride is indicated in the management of manifestations of psychotic disorders. Fluphenazine hydrochloride has not been shown effective in the management of behavioral complications in patients with mental retardation. Phenothiazines are contraindicated in patients with suspected or established subcortical brain damage, in patients receiving large doses of hypnotics, and in comatose or severely depressed states. The presence of blood dyscrasia or liver damage precludes the use of fluphenazine hydrochloride. Fluphenazine hydrochloride is contraindicated in patients who have shown hypersensitivity to fluphenazine; cross-sensitivity to phenothiazine derivatives may occur.
Fluphenazine Hydrochloride Tablets, USP are available containing either 5 mg or 10 mg of fluphenazine hydrochloride, USP. The 5 mg tablets are green film-coated, triangular shaped tablets debossed with M on one side of the tablet and 74 on the other side. They are available as follows: NDC 0615-1501-39 blistercards of 30 tablets The 10 mg tablets are orange film-coated, triangular shaped tablets debossed with M on one side of the tablet and 97 on the other side. They are available as follows: NDC 0615-3574-39 blistercards of 30 tablets Store at 20° to 25°C (68° to 77°F). [See USP for Controlled Room Temperature.] Protect from light. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.
Abbreviated New Drug Application
FLUPHENAZINE HYDROCHLORIDE- FLUPHENAZINE HYDROCHLORIDE TABLET, FILM COATED NCS HEALTHCARE OF KY, INC DBA VANGARD LABS ---------- FLUPHENAZINE HYDROCHLORIDE TABLETS, USP 1 MG, 2.5 MG, 5 MG AND 10 MG RX ONLY DESCRIPTION Fluphenazine hydrochloride is a trifluoromethyl phenothiazine derivative intended for the management of schizophrenia. Chemically it is 4-[3-[2-(Trifluoromethyl) phenothiazin-10-yl]propyl]-1-piperazine- ethanol dihydrochloride which may be represented by the following structural formula: C H F N OS•2HCl M.W. 510.44 Each tablet, for oral administration, contains 1 mg, 2.5 mg, 5 mg, or 10 mg of fluphenazine hydrochloride, USP per tablet. Inactive ingredients are: hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, pregelatinized starch, sodium lauryl sulfate and titanium dioxide. The following additional product specific inactive ingredients are employed: 1 mg – calcium sulfate, hydroxypropyl cellulose and talc 2.5 mg – lecithin, polydextrose, sodium alginate and triacetin 5 mg – hydroxypropyl cellulose 10 mg – lecithin, polydextrose, sodium alginate and triacetin The following coloring agents are employed: 2.5 mg – D&C Yellow No. 10 Aluminum Lake, FD&C Yellow No. 6 Aluminum Lake 5 mg – FD&C Blue No. 1 Aluminum Lake, D&C Yellow No. 10 Aluminum Lake, FD&C Yellow No. 6 Aluminum Lake 10 mg – FD&C Yellow No. 6 Aluminum Lake. CLINICAL PHARMACOLOGY Fluphenazine hydrochloride has activity at all levels of the central nervous system as well as on multiple organ systems. The mechanism whereby its therapeutic action is exerted is unknown. 22 26 3 3 INDICATIONS AND USAGE Fluphenazine hydrochloride is indicated in the management of manifestations of psychotic disorders. Fluphenazine hydrochloride has not been shown effective in the management of behavioral complications in patients with mental retardation. CONTRAINDICATIONS Phenothiazines are contraindicated in patients with suspected or established subcortical brain damage, in patients receiving large doses of hypno Read the complete document